CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Surgery Partners Inc   (SGRY)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

SGRY's Net Income Growth by Quarter and Year

Surgery Partners Inc 's Net Income results by quarter and year




SGRY Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 46.70 23.30 42.90
III Quarter September - 29.70 5.60 8.20
II Quarter June 28.40 57.70 15.30 8.80
I Quarter March 24.30 1.20 42.80 10.80
FY   52.70 135.30 87.00 70.70



SGRY Net Income second quarter 2024 Y/Y Growth Comment
Surgery Partners Inc reported drop in Net Income in the second quarter 2024 by -50.78% to $ 28.40 millions, from the same quarter in 2023.
The fall in the second quarter 2024 Surgery Partners Inc 's Net Income compares unfavorably to the Company's average Net Income doubling of 244.5%.

Looking into second quarter 2024 results within Healthcare Facilities industry 2 other companies have achieved higher Net Income growth. While Surgery Partners Inc ' s Net Income meltdown of -50.78% ranks overall at the positon no. 178 in the second quarter 2024.


SGRY Net Income ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December - 100.43 % -45.69 % -10.44 %
III Quarter September - 430.36 % -31.71 % -
II Quarter June -50.78 % 277.12 % 73.86 % -
I Quarter March 1925 % -97.2 % 296.3 % -
FY   - 55.52 % 23.06 % 5338.46 %

Financial Statements
Surgery Partners Inc 's second quarter 2024 Net Income $ 28.40 millions SGRY's Income Statement
Surgery Partners Inc 's second quarter 2023 Net Income $ 57.70 millions Quarterly SGRY's Income Statement
New: More SGRY's historic Net Income Growth >>


SGRY Net Income (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - 57.24 % 316.07 % 423.17 %
III Quarter September - -48.53 % -63.4 % -6.82 %
II Quarter June 16.87 % 4708.33 % -64.25 % -18.52 %
I Quarter March -47.97 % -94.85 % -0.23 % -77.45 %
FY (Year on Year)   - 55.52 % 23.06 % 5338.46 %


Compare SGRY Profitability >> Back to SGRY Growth rate Comparisons >>


Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #3
Healthcare Sector #20
Overall #178

Net Income Y/Y Growth Statistics
High Average Low
5338.46 % 244.5 % -258.25 %
(Dec 31 2021)   (Sep 30 2019)
Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #3
Healthcare Sector #20
Overall #178
Net Income Y/Y Growth Statistics
High Average Low
5338.46 % 244.5 % -258.25 %
(Dec 31 2021)   (Sep 30 2019)

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Surgery Partners Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
4708.33 % 223.69 % -94.85 %
(Jun 30 2023)  


SGRY's II. Quarter Q/Q Net Income Comment
Surgery Partners Inc achieved in the II. Quarter 2024 below company average Net Income jump of 16.87% quarter on quarter, to $ 28.40 millions.

Within Healthcare Facilities industry 4 other companies have achieved higher Net Income quarter on quarter growth. While Surgery Partners Inc 's Net Income growth quarter on quarter, overall rank is 599.


Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #44
Overall #599
Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #44
Overall #599
Net Income Q/Q Growth Statistics
High Average Low
4708.33 % 223.69 % -94.85 %
(Jun 30 2023)  


SGRY's II. Quarter Q/Q Net Income Comment
Surgery Partners Inc achieved in the II. Quarter 2024 below company average Net Income jump of 16.87% quarter on quarter, to $ 28.40 millions.

Within Healthcare Facilities industry 4 other companies have achieved higher Net Income quarter on quarter growth. While Surgery Partners Inc 's Net Income growth quarter on quarter, overall rank is 599.


Surgery Partners Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)
Cumulative Net Income 12 Months Ending $ 129.10 $ 158.40 $ 135.30 $ 111.90 $ 87.80
Y / Y Net Income Growth (TTM) 47.04 % 248.9 % 55.52 % 4.97 % -19.6 %
Year on Year Net Income Growth Overall Ranking # 990 # 1331 # 398 # 267 # 21
Seqeuential Net Income Change (TTM) -18.5 % 17.07 % 20.91 % 27.45 % 93.39 %
Seq. Net Income Growth (TTM) Overall Ranking # 178 # 1272 # 919 # 670 # 247

New: More SGRY's historic Net Income Growth >>



Cumulative Net Income growth Comment
With the quarterly Net Income reported in the Jun 30 2024 period, Surgery Partners Inc 's cumulative twelve months Net Income were $ 129 millions, company would post below average annual Net Income growth of 93.39% year on year, if the fiscal year would end at Jun 30 2024.
A slow-down in the Surgery Partners Inc 's Net Income growth from the 24.3% growth in Mar 31 2024.

In the Healthcare sector 72 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 990, from total ranking in previous quarter at 1331.

Net Income TTM Q/Q Growth Statistics
High Average Low
5338.46 %
244.5 %
-258.25 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 3
Healthcare Sector # 73
Overall # 990

Net Income TTM Y/Y Growth Statistics
High Average Low
5338.46 %
244.5 %
-258.25 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 20
S&P 500 # 178
Cumulative Net Income growth Comment
With the quarterly Net Income reported in the Jun 30 2024 period, Surgery Partners Inc 's cumulative twelve months Net Income were $ 129 millions, company would post below average annual Net Income growth of -258.25% year on year, if the fiscal year would end at Jun 30 2024.
A slow-down in the Surgery Partners Inc 's Net Income growth from the 24.3% growth in Mar 31 2024.

In the Healthcare sector 72 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 990, from total ranking in previous quarter at 1331.

Net Income TTM Q/Q Growth Statistics
High Average Low
5338.46 %
244.5 %
-258.25 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 3
Healthcare Sector # 73
Overall # 990

Net Income TTM Y/Y Growth Statistics
High Average Low
5338.46 %
244.5 %
-258.25 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 20
S&P 500 # 178




Other Net Income Growth
Healthcare Facilities Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
SGRY's Net Income Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for SGRY's Competitors
Net Income Growth for Surgery Partners Inc 's Suppliers
Net Income Growth for SGRY's Customers

You may also want to know
SGRY's Annual Growth Rates SGRY's Profitability Ratios SGRY's Asset Turnover Ratio SGRY's Dividend Growth
SGRY's Roe SGRY's Valuation Ratios SGRY's Financial Strength Ratios SGRY's Dividend Payout Ratio
SGRY's Roa SGRY's Inventory Turnover Ratio SGRY's Growth Rates SGRY's Dividend Comparisons



Companies with similar Net Income jump for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2024
Biogen Inc -1.63%$ -1.635 millions
Embecta Corp -3.29%$ -3.289 millions
Quest Diagnostics Inc-3.61%$ -3.614 millions
Abbott Laboratories-5.31%$ -5.309 millions
Zoetis Inc -6.87%$ -6.866 millions
Idexx Laboratories Inc-9.34%$ -9.337 millions
Prestige Consumer Healthcare Inc -11.89%$ -11.893 millions
Align Technology inc -13.64%$ -13.639 millions
National Research Corporation-15.10%$ -15.097 millions
Dariohealth Corp -17.94%$ -17.938 millions
Bristol myers Squibb Company-18.92%$ -18.922 millions
Organon and Co -19.42%$ -19.421 millions
U S Physical Therapy Inc-21.21%$ -21.206 millions
Pacira Biosciences inc -26.69%$ -26.693 millions
Privia Health Group Inc -27.00%$ -26.997 millions
West Pharmaceutical Services Inc -28.24%$ -28.240 millions
Neurocrine Biosciences Inc -31.94%$ -31.937 millions
Abbvie Inc -32.26%$ -32.264 millions
Lifevantage Corp-33.62%$ -33.622 millions
Lantheus Holdings Inc -34.06%$ -34.057 millions
Viemed Healthcare Inc -36.61%$ -36.609 millions
Vaso Corporation-44.26%$ -44.257 millions
Nature s Sunshine Products inc -44.42%$ -44.415 millions
Royalty Pharma Plc-44.67%$ -44.675 millions
Globus Medical Inc -44.97%$ -44.968 millions
Amgen Inc -45.90%$ -45.903 millions
Surgery Partners Inc -50.78%$ -50.780 millions
Radnet Inc -52.29%$ -52.294 millions
Option Care Health Inc -53.63%$ -53.635 millions
Pro dex Inc -58.30%$ -58.303 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com